Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 5
2019 3
2020 1
2021 1
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Asurza-Veliz
Page 1
Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia.
Walker Z, Gandolfo F, Orini S, Garibotto V, Agosta F, Arbizu J, Bouwman F, Drzezga A, Nestor P, Boccardi M, Altomare D, Festari C, Nobili F; EANM-EAN Task Force for the recommendation of FDG PET for Dementing Neurodegenerative Disorders. Walker Z, et al. Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1534-1545. doi: 10.1007/s00259-018-4031-2. Epub 2018 May 19. Eur J Nucl Med Mol Imaging. 2018. PMID: 29779045 Free PMC article. Review.
Reduction in Left Frontal Alpha Oscillations by Transcranial Alternating Current Stimulation in Major Depressive Disorder Is Context Dependent in a Randomized Clinical Trial.
Riddle J, Alexander ML, Schiller CE, Rubinow DR, Frohlich F. Riddle J, et al. Biol Psychiatry Cogn Neurosci Neuroimaging. 2022 Mar;7(3):302-311. doi: 10.1016/j.bpsc.2021.07.001. Epub 2021 Jul 14. Biol Psychiatry Cogn Neurosci Neuroimaging. 2022. PMID: 34273556 Free PMC article. Clinical Trial.
Exploring the complex interrelation between depressive symptoms, risk, and protective factors: A comprehensive network approach.
Iovoli F, Hall M, Nenadic I, Straube B, Alexander N, Jamalabadi H, Jansen A, Stein F, Brosch K, Thomas-Odenthal F, Usemann P, Teutenberg L, Wroblewski A, Pfarr J, Thiel K, Flinkenflügel K, Meinert S, Grotegerd D, Hahn T, Goltermann J, Gruber M, Repple J, Enneking V, Winter A, Dannlowski U, Kircher T, Rubel JA. Iovoli F, et al. J Affect Disord. 2024 Mar 26;355:12-21. doi: 10.1016/j.jad.2024.03.119. Online ahead of print. J Affect Disord. 2024. PMID: 38548192 Free article.
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia.
Bouwman F, Orini S, Gandolfo F, Altomare D, Festari C, Agosta F, Arbizu J, Drzezga A, Nestor P, Nobili F, Walker Z, Morbelli S, Boccardi M; EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders. Bouwman F, et al. Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1526-1533. doi: 10.1007/s00259-018-4034-z. Epub 2018 May 9. Eur J Nucl Med Mol Imaging. 2018. PMID: 29744573 Free PMC article.